New hope for stubborn hip pain: TAME vs PRP showdown
NCT ID NCT07396246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two minimally invasive treatments for people with long-lasting hip pain (Greater Trochanteric Pain Syndrome). Participants will receive either a targeted artery treatment (TAME) or a platelet-rich plasma (PRP) injection. The goal is to see which one reduces pain and improves daily function better over a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TROCHANTERIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unidade Local de Saúde do Alto Ave
RECRUITINGGuimarães, Portugal